Filing Details

Accession Number:
0001628280-23-018931
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-05-18 19:18:04
Reporting Period:
2023-05-09
Accepted Time:
2023-05-18 19:18:04
Original Submission Date:
2023-05-10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1551306 Progyny Inc. PGNY Services-Misc Health & Allied Services, Nec (8090) 272220139
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1576147 Peter Anevski C/O Progyny, Inc.
1359 Broadway, 2Nd Floor
New York NY 10018
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-05-09 6,095 $37.61 71,318 No 4 S Indirect See footnote
Common Stock Disposition 2023-05-09 1,568 $38.24 69,750 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.05 to $38.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $38.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The amount reported in Column 5 of Table I reflects the number of shares of common stock indirectly held by the Reporting Person as of the date of the original Form 4 filing on May 10, 2023.